NatashaRekhtmanMD

PubMed

• All that is small is not a small cell carcinoma: Thoracic SMARCA4 undifferentiated tumors masquerading as SCLC.
  Rekhtman, N.> ;Clinical Cancer Research. 2024 Feb 28
• Pathologic Assessment and Staging of Multiple Non-Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods.
  Natasha Rekhtman, Jason C Chang> ;Modern Pathology. 2024 Feb 21
• 2 citations
  Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
  Jerome, J., Sanja Dacic, Xuanye Cao, Neus Bota-Rabassedas, Beatriz Sanchez-Espiridion, Sabina Berezowska, Yuchen Han, Jin-Haeng Chung, Mary Beth Beasley, Lin Dongmei, ...> ;Journal of Thoracic Oncology. 2024 Feb 1
• First-in-human imaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.
  Tendler, S., Dunphy, M., Agee, M., O'Donoghue, J., Aly, R., Choudhury, N., Kesner, A., Kirov, A., Mauguen, A., Baine, M., Schoder, H., Weber, W., Rekhtman, N., Lyashch...> ;Medrxiv. 2024 Jan 11
• Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma.
  Christopher A Febres-Aldana, Jason C Chang, Achim A Jungbluth, Prasad S Adusumilli, Francis M Bodd, Denise Frosina, Jerica A Geronimo, Enmily Hernandez, Helen Irawan, ...> ;Modern Pathology. 2024 Mar 1
• Adamantinoma-like Ewing Sarcoma (ALES) May Harbor FUS Rearrangements : A Potential Diagnostic Pitfall.
  Doreen N Palsgrove, Robert D Foss, Wengdong Yu, Joaquin Garcia, Lisa M Rooper, Natasha Rekhtman, Cristina Antonescu, Jeffrey Gagan, Abbas Agaimy, Justin A Bishop> ;The American Journal of Surgical Pathology. 2023 Nov 1
• 3 citations
  Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology.
  Brie Kezlarian, Joseph Montecalvo, Francis M Bodd, Jason C Chang, Elyn Riedel, Charlie White, Natasha Rekhtman, Jennifer L Sauter> ;Cancer Cytopathology. 2023 Aug 1
• 1 citations
  Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytop...
  Yan Li, Abeer M Salama, Marina K Baine, Francis M Bodd, Michael D Offin, Natasha Rekhtman, Marjorie G Zauderer, William D Travis, Prasad S Adusumilli, Jennifer L Sauter> ;Cancer Cytopathology. 2023 Aug 1
• 16 citations
  Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
  Takahiro Karasaki, David A Moore, Selvaraju Veeriah, Cristina Naceur-Lombardelli, Antonia Toncheva, Neil Magno, Sophia Ward, Maise Al Bakir, Thomas B K Watkins, Kristi...> ;Nature Medicine. 2023 Apr 1
• 25 citations
  Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers.
  Noura J Choudhury, Antonio Marra, Jane S Y Sui, Jessica Flynn, Soo-Ryum Yang, Christina J Falcon, Pier Selenica, Adam J Schoenfeld, Natasha Rekhtman, Daniel Gomez, Mic...> ;Journal of Thoracic Oncology. 2023 Apr 1
• 39 citations
  Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
  Justin Jee, Emily S Lebow, Randy Yeh, Jeeban P Das, Azadeh Namakydoust, Paul K Paik, Jamie E Chaft, Gowtham Jayakumaran, A Rose Brannon, Ryma Benayed, Ahmet Zehir, Mar...> ;Nature Medicine. 2022 Nov 1
• 10 citations
  Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies.
  Kenta Kawasaki, Natasha Rekhtman, Álvaro Quintanal-Villalonga, Charles M Rudin> ;Nature Reviews. Clinical Oncology. 2023 Jan 1
• 3 citations
  A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos.
  Yuan Liu, Neel Chudgar, Brooke Mastrogiacomo, Di He, Manendra B Lankadasari, Samhita Bapat, Gregory D Jones, Francisco Sanchez-Vega, Kay See Tan, Nikolaus Schultz, Sem...> ;Science Translational Medicine. 2022 Oct 5
• 4 citations
  Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours.
  Omid Savari, Christopher Febres-Aldana, Jason C Chang, Rachel E Fanaroff, Katia Ventura, Francis Bodd, Paul Paik, Murty Vundavalli, Anjali Saqi, Frederic B Askin, Will...> ;Histopathology. 2023 Jan 1
• 2 citations
  Small Biopsy and Cytology of Pulmonary Neuroendocrine Neoplasms: Brief Overview of Classification, Immunohistochemistry, Molecular Profiles, and World Health Organizat...
  Simon Sung, Jonas J Heymann, Michelle Garlin Politis, Marina K Baine, Natasha Rekhtman, Anjali Saqi> ;Advances in Anatomic Pathology. 2022 Nov 1
• Evaluation of an Integrated Spectroscopy and Classification Platform for Point-of-Care Core Needle Biopsy Assessment: Performance Characteristics from Ex Vivo Renal Ma...
  Krishna Nand Keshavamurthy, Dmitry V Dylov, Siavash Yazdanfar, Dharam Patel, Tarik Silk, Mikhail Silk, Frederick Jacques, Elena N Petre, Mithat Gonen, Natasha Rekhtman...> ;Journal of Vascular and Interventional Radiology. 2022 Nov 1
• 4 citations
  SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Recepto...
  Hiroki Sato, Daisuke Kubota, Huan Qiao, Achim Jungbluth, Natasha Rekhtman, Adam J Schoenfeld, Helena A Yu, Gregory J Riely, Shinichi Toyooka, Christine M Lovly, Paul P...> ;JCO Precision Oncology. 2022 Aug 1
• 4 citations
  First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case Report.
  Omid Savari, Jason C Chang, Justin A Bishop, Muthu Kumar Sakthivel, Frederic B Askin, Natasha Rekhtman> ;Journal of Thoracic Oncology. 2022 Aug 1
• 11 citations
  Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset.
  Christopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, Yuhan Wang, Erika Gedvilaite, Marina K Baine, William D Travis, Katia Ventura, Francis Bodd, Helena A Yu, Al...> ;Clinical Cancer Research. 2022 Nov 1
• 3 citations
  Immune check-point inhibitor-related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease.
  Saira Imran, Andrew Golden, Marc Feinstein, Andrew Plodkowski, Francis Bodd, Natasha Rekhtman, William D Travis, Diane E Stover, Jennifer L Sauter> ;Histopathology. 2022 Dec 1
• 28 citations
  POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.
  Marina K Baine, Christopher A Febres-Aldana, Jason C Chang, Achim A Jungbluth, Shenon Sethi, Cristina R Antonescu, William D Travis, Min-Shu Hsieh, Mee Sook Roh, Rober...> ;Journal of Thoracic Oncology. 2022 Sep 1
• 3 citations
  Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3.
  Elaine Zhong, Fresia Pareja, Matthew G Hanna, Achim A Jungbluth, Natasha Rekhtman, Edi Brogi> ;Human Pathology. 2022 Sep 1
• 20 citations
  CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.
  Rocio Perez-Johnston, Jose A Araujo-Filho, James G Connolly, Raul Caso, Karissa Whiting, Kay See Tan, Jian Zhou, Peter Gibbs, Natasha Rekhtman, Michelle S Ginsberg, Da...> ;Radiology. 2022 Jun 1
• 6 citations
  NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cyt...
  Deepali Jain, Aruna Nambirajan, Gang Chen, Kim Geisinger, Kenzo Hiroshima, Lester Layfield, Yuko Minami, Andre L Moreira, Noriko Motoi, Mauro Papotti, Natasha Rekhtman...> ;Journal of Thoracic Oncology. 2022 Jun 1
• 9 citations
  Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing Data.
  Chad M Vanderbilt, Anita S Bowman, Sumit Middha, Kseniya Petrova-Drus, Yi-Wei Tang, Xin Chen, Youxiang Wang, Jason Chang, Natasha Rekhtman, Klaus J Busam, Sounak Gupta...> ;The Journal of Molecular Diagnostics. 2022 May 1
• Join now to see all

Journal Articles

• PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung Cancers  
  G J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
• Pathologic Features of Response to Neoadjuvant Anti-PD-1 in Resected Non-Small Cell Lung Carcinoma: A Proposal for Quantitative Immune-Related Pathologic Response Crit...  
  J M Isbell, N Rekhtman, J D Wolchok, J E Chaft, Annals of Oncology